SoftBank led a $600m Series D funding round in CMR Surgical, a British medical technology company. The round had participation from investors Ally Bridge Group, RPMI Railpen, Tencent, Chimera, LGT, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare. “This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion. As the lead investor, SoftBank has a wealth of experience supporting disruptive business models and innovative technologies, and we look forward to leveraging their expertise and extensive ecosystem," Per Vegard Nerseth, CMR Surgical CEO.